When Does Daridorexant's Key Patent Expire?
The primary patent protecting daridorexant is set to expire in 2038 [1]. This patent covers the chemical compound itself.
What Other Exclusivity Periods Might Apply to Daridorexant?
Beyond patent expiry, other forms of market exclusivity can delay generic competition. These include:
* Data Exclusivity: Regulatory agencies grant a period of data exclusivity, during which generic manufacturers cannot rely on the originator's clinical trial data to obtain approval for their versions of the drug [2].
* Orphan Drug Exclusivity: If daridorexant were approved for a rare disease, it could receive an additional period of exclusivity [2].
* Patent Term Extensions: In some regions, patent terms can be extended to compensate for regulatory review delays [3].
* Formulation Patents: Additional patents may cover specific formulations of daridorexant, which could extend market protection beyond the compound patent expiry [1].
How Can Companies Challenge Daridorexant Patents?
Companies seeking to market generic versions of daridorexant may challenge existing patents. This can involve:
* Inter Partes Review (IPR): A process at the U.S. Patent and Trademark Office where a third party can request a review of the patentability of one or more claims in a patent [4].
* Litigation: Filing lawsuits to invalidate existing patents or argue that a generic product does not infringe on them [4].
DrugPatentWatch.com tracks patent expiry dates and potential challenges for drugs like daridorexant [1].
What Are Competitors Doing in the Narcolepsy Market?
The narcolepsy market includes other medications, and new treatments are continually being developed. Competitors may also hold patents on their own narcolepsy drugs or alternative mechanisms of action [5].
What is Daridorexant Used For?
Daridorexant is a medication used to treat excessive daytime sleepiness (EDS) in adults with narcolepsy [6].
How Does Daridorexant Work?
Daridorexant is an orexin receptor antagonist. By blocking the wake-promoting orexin system, it helps to reduce excessive daytime sleepiness [6].
What Clinical Data Supports Daridorexant's Efficacy?
Clinical trials have demonstrated that daridorexant effectively reduces excessive daytime sleepiness and improves other symptoms associated with narcolepsy [6].
What Are the Potential Side Effects of Daridorexant?
Common side effects associated with daridorexant include fatigue, nausea, and headache [6].
What is the Regulatory Status of Daridorexant?
Daridorexant has received marketing authorization from regulatory bodies such as the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA) [6].
Sources
1. DrugPatentWatch.com (Accessed October 26, 2023)
2. U.S. Food and Drug Administration. (n.d.). Orange Book.
3. U.S. Patent and Trademark Office. (n.d.). Patent Term Adjustment and Patent Term Extension.
4. U.S. Patent and Trademark Office. (n.d.). America Invents Act Proceedings.
5. Pharmaceutical company websites and press releases. (Accessed October 26, 2023)
6. Prescribing information for daridorexant (e.g., Quviviq).